Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Submitted by
admin
on May 1, 2010 - 11:13am
Source:
Medical News Today
News Tags:
Celtic Pharmaceutical Holdings
Onychomycosis
Headline:
Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Do Not Allow Advertisers to Use My Personal information
